Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Comment by Craiger02on Oct 30, 2021 12:39pm
137 Views
Post# 34068324

RE:RE:Don't kid yourself there is a raise coming , Tetra cash burn

RE:RE:Don't kid yourself there is a raise coming , Tetra cash burn

that first part is not true at all. With the warrants, they are handed out as perks to the investors in the raise. It is extremely common to have them on 3-4 year exercise options. Not sure how you came to the conclusion that they don't anticipate a SP over 40 cents in your mentioned statement. Simply false. With the strike price where it is, any decent movement upwards makes these very attractive investments to flip or convert in 2024


SamV21 wrote: and with the warrants the company is betting the price will not go over .40 cents for a long time , that tells you how confident they are , have any of the warrants Tetra have issues ever been exersized . Even after any approval they have of anything they still have  to promote and compete for market share ,they still have never mentioned the cost of any of their products , are they compedative in the market place? .Right now Teva makes Nabilone that is very similar to Reduvo.And Qixleef has to compete with Sqye that Tilray and Teva have health canada approved already, Tetra is not making original medications , other companies make antinausea meds for cancer, other Drug companies make lots of pain medications.  That is what happens to drug companies , it takes money to make money , the price may go up but there will be another raise ,you can bet on it. No new news , updates don't put money in the pockets of shareholders ,its all just  self promo, hype and paid pumping so the pump and dump can happen once again, wait for the results, nothing real has changed here or will change here until there are confirmed results from Health Canada.And Qixleef is years away from ever making a penny.

 

<< Previous
Bullboard Posts
Next >>